Table 4.
Variable | Data Available | Coefficient | OR (95% CI) | p-Value | AUC (95% CI) |
Age (years) | 96, 100% (63 R-SRL, 33 S-SRL) |
−0.03 | 0.97 (0.93–1.0008) | 0.056 | 0.6 (0.5–0.7) |
Low-grade SSTR2 expression | 89, 92.7% (61 R-SRL, 28 S-SRL) |
1.43 | 4.17 (1.29–13.49) | 0.017 | 0.63 (0.52–0.73) |
T2-iso/hyper-intensity | 73, 76% (52 R-SRL, 21 S-SRL) |
1.19 | 3.3 (1.14–9.54) | 0.027 | 0.64 (0.52–0.75) |
SG/intermediate CAM5.2 pattern | 96, 100% (63 R-SRL, 33 S-SRL) |
0.8 | 2.24 (0.95–5.28) | 0.066 | 0.6 (0.49–0.7) |
Abbreviations: OR, odds ratio; CI, confidence interval; AUC, area under the curve; R-SRL, patients resistant to somatostatin receptor ligands; S-SRL, patients responsive to somatostatin receptor ligands; SSTR2, somatostatin receptor type 2; SG, sparsely granulated.